Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+50.1%
5Y CAGR+67.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+50.1%/yr
Annual compound
5Y CAGR
+67.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
13.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$161.44M+102.0%
2023$79.93M-44.2%
2022$143.24M+200.3%
2021$47.70M-36.3%
2020$74.85M+507.2%
2019$12.33M-85.1%
2018$82.52M-